Besides following our news, follow us on socials networks :
Targovax demonstrates the “Synergistic effect of oncolytic virus combined with anti-PD-1 against Melanoma”. TransCure’s hu-mouse are the preferred in vivo models for combination therapy evaluation.
Besides being present at I4ID event, Sébastien Tabruyn, our CSO, will give a pitch for answering one question : “How humanized mice models helps to evaluate immunotherapy for infectious Diseases?”
TransCure team has just acquired a second AttuneTM NxT Flow Cytometer. With this new cytometer, the scientific team will be able to carry out more accurate studies, analyze more sample types and expand its capabilities.
Patrick Nef, CEO at TransCure reacts to Jim Allison and Tasuku Honjo’s awards for their research on immunotherapy.
Find more about TransCure humanized mice models which makes it possible to test novel anti-HIV treatments on infected animal models with a fully functional human immune system!